Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bedford, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Anika Therapeutics, Inc. has filed 1,096 SEC EDGAR filings since 22 Feb 1996

SEC filing history

Showing 476-500 of 768 matching filings.

Per page
25
Current page
20
4

OWNERSHIP DOCUMENT

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Feb 2017
Reporting date
22 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Feb 2017
Reporting date
22 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

ANIKA THERAPEUTICS, INC. 8-K

Filing date
15 Feb 2017
Reporting date
15 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-45573

SC 13G filing

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45573

SCHEDULE 13G/A

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45573

SEC SCHEDULE 13G

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

FORM 8-K

Filing date
08 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45573

13G/A

Filing date
06 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

FORM 8-K

Filing date
27 Jan 2017
Reporting date
23 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45573

SC 13G/A filing

Filing date
12 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .